EU Calls for proposal 2021
Spurred by COVID-19 and rising challenges to the financial sustainability of Europe’s health systems, a flurry of new EU policies and programs in health has sprung up since last year. Some of the most eye-catching initiatives are highly relevant for hematology: the Europe’s Beating Cancer Plan, the Pharmaceutical Strategy and the European Health Data Space.
For years, EHA together with other medical societies and patient organizations has been advocating for EU-level strategies or collaboration around topics that are now central to the EU’s new policies: accessibility and affordability; patient-centric, unmet needs based development of medicines; dedicated regulatory and data frameworks for personalized medicine and rare diseases. Find EHA’s position papers here.
The EU’s priorities in health policy are reflected in its new multiannual (2021-2027) funding programs. The programs most closely monitored by EHA are:
- Horizon Europe, the EU framework program for research and innovation with a dedicated Health Cluster and Cancer Mission.
- EU4Health, the EU’s response to the COVID pandemic. EU4Health provides action grants to boost the crisis preparedness and resilience of European health systems, and to support the objectives of the Beating Cancer Plan and Pharmaceutical Strategy.
Below is an overview of recently published calls with relevance for hematology.
EU4Health calls for proposals (deadline January 25, 2022)
- Action grants boosting cancer prevention through the use of the European Code against Cancer and other concerted actions
- Action grants to organise and collect data to understand the safety, quality and efficacy of therapies applied in the field of assisted reproduction and based on haematopoietic stem cells
- Action grants for ‘Cancer Diagnostic and Treatment for All’ including ‘Genomic for Public Health’
- Action grants for the Computer-aided Drug Repurposing for Cancer Therapy Project
- Action grants for developing a pilot project for an EU infrastructure ecosystem for the secondary use of health data for research, policy-making and regulatory purposes
- Action grants for ‘EU Cancer Treatment Capacity and Capability Mapping’ project - Network of Comprehensive Cancer Centres
- Action grants to create a ‘Cancer Survivor Smart Card’
- Development of new effective therapies for rare diseases: deadlines February 1, 2022 (Stage 1) and September 6, 2022 (Stage II)
- Non-communicable diseases risk reduction in adolescence and youth (Global Alliance for Chronic Diseases – GACD): deadline April 21, 2022
- Setting up a European Smart Health Innovation Hub: deadline April 21, 2022
- Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs: deadlines February 1, 2022 (Stage I) and September 6, 2022 (Stage II)
- Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers: deadline April 21, 2022